OPKO Health, Inc.

    Jurisdiction
    United States
    LEI
    529900A4S2D4OGOJLL02
    ISIN
    US68375N1037 (OPK)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    InsiderPie Expert Score
    50 / 100
    Worse than peer group:
    57 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. Read full profile

    Fundamentals

    Net revenue
    €566.38M
    Gross margin
    32.7%
    EBIT
    -€124.59M
    EBIT margin
    -22.0%
    Net income
    -€151.09M
    Net margin
    -26.7%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €544.05M -3.9% -€153.82M +1.8%
    €615.02M +13.0% -€55.44M -64.0%
    €591.10M -3.9% -€46.40M -16.3%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Frost Gamma Investments Trust CEO & Chairman +675K $1.32 +$891.00K

    Earnings Calls

    Earnings Calls

    Latest earnings call: May 7, 2024 (Q1 2024)

    Add to watchlist

    Notifications